Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Xu Wan
Economic Evaluation of Dapagliflozin Versus Metformin in Chinese Patients Whose Diabetes Is Inadequately Controlled With Diet and Exercise
Cost Effectiveness and Resource Allocation
Health Policy
Related publications
Cost-Effectiveness of First-Line Versus Delayed Use of Combination Dapagliflozin and Metformin in Patients With Type 2 Diabetes
Scientific Reports
Multidisciplinary
Effects of Vildagliptin on Glucose Control Over 24 Weeks in Patients With Type 2 Diabetes Inadequately Controlled With Metformin
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Db4 - Cost-Effectiveness of Dapagliflozin in Adult Patients With Inadequately Controlled Type 1 Diabetes: A Health Economic Analysis Using 24-Week Results From the Depict-1 Randomised Controlled Trial
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Comparison of Nateglinide and Gliclazide in Combination With Metformin, for Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Maximum Doses of Metformin Alone
Diabetic Medicine
Internal Medicine
Endocrinology
Metabolism
Diabetes
Effects of Dapagliflozin, an SGLT2 Inhibitor, on HbA1c, Body Weight, and Hypoglycemia Risk in Patients With Type 2 Diabetes Inadequately Controlled on Pioglitazone Monotherapy
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Efficacy and Safety of Diacerein in Patients With Inadequately Controlled Type 2 Diabetes: A Randomized Controlled Trial
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Dose-Dependent Effects of the Once-Daily GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes Inadequately Controlled With Metformin: A Randomized, Double-Blind, Placebo-Controlled Trial
Diabetic Medicine
Internal Medicine
Endocrinology
Metabolism
Diabetes
Efficiency and Safety of Transfer of Type 2 Diabetes Patients Inadequately Controlled on Metformin Alone to Combined Therapy Withmetformin and Diabeton MB
Diabetes Mellitus
Internal Medicine
Endocrinology
Metabolism
Diabetes